Discussion
The U.S. Food and Drug Administration (FDA) has lifted the hold on late-stage clinical testing of ARD-101, an investigational oral therapy for people with Prader-Willi syndrome (PWS) and hyperphagia, an insatiable feeling of hunger. “We are pleased that the FDA has lifted the clinical hold on ARD-101, allowing…